Bin Peng

429 total citations
22 papers, 307 citations indexed

About

Bin Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bin Peng has authored 22 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Bin Peng's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (4 papers). Bin Peng is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (4 papers). Bin Peng collaborates with scholars based in China, United States and France. Bin Peng's co-authors include Guanggui Ding, Tonghai Huang, Zheng Wang, Guangsuo Wang, Yuxin Wen, Lin Yang, Jun Wan, Li Chen, Chao Li and Lei Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Frontiers in Plant Science.

In The Last Decade

Bin Peng

21 papers receiving 304 citations

Peers

Bin Peng
Xiong Lei China
Xu Xiao China
Deven Patel United States
Stephanie Dorman United States
Ok‐Seon Kwon South Korea
Bin Peng
Citations per year, relative to Bin Peng Bin Peng (= 1×) peers Yunfeng Zhu

Countries citing papers authored by Bin Peng

Since Specialization
Citations

This map shows the geographic impact of Bin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Peng more than expected).

Fields of papers citing papers by Bin Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Peng. The network helps show where Bin Peng may publish in the future.

Co-authorship network of co-authors of Bin Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Peng. A scholar is included among the top collaborators of Bin Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Peng. Bin Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Long, Wanying Lin, Bin Peng, et al.. (2025). Laminin β1 stimulates the Hippo-YAP1 pathway to advance the progression and lenvatinib resistance in hepatocellular carcinoma. International Journal of Biological Macromolecules. 336. 149150–149150.
2.
Liu, Kexin, Jiahuan Liu, Chunmei Yin, et al.. (2024). Analysis of sugar components and identification of SPS genes in citrus fruit development. Frontiers in Plant Science. 15. 1372809–1372809. 12 indexed citations
3.
Jia, Sheng, et al.. (2022). The Microbiota and Cytokines Correlation between the Jejunum and Colon in Altay Sheep. Animals. 12(12). 1564–1564. 7 indexed citations
4.
Guo, Yanhua, Guofeng Li, Mingming Xu, & Bin Peng. (2022). A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma. Computers in Biology and Medicine. 148. 105655–105655. 3 indexed citations
5.
Feng, Song, et al.. (2022). Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment. World Journal of Clinical Cases. 10(31). 11299–11312. 1 indexed citations
6.
Peng, Bin, et al.. (2022). Investigation of the binding behavior of bioactive 7-methoxyflavone to human serum albumin by coupling multi-spectroscopic with computational approaches. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 285. 121920–121920. 4 indexed citations
7.
Peng, Bin, et al.. (2022). Glucosamine‐phosphate N‐acetyltransferase 1 and its DNA methylation can be biomarkers for the diagnosis and prognosis of lung cancer. Journal of Clinical Laboratory Analysis. 36(9). e24628–e24628. 7 indexed citations
8.
Wang, Zechen, et al.. (2021). Potential lncRNA Biomarkers for HBV‐Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network. BioMed Research International. 2021(1). 9972011–9972011. 12 indexed citations
9.
Li, Chao, et al.. (2020). <p>LncRNA HCP5 Stimulates the Proliferation of Non-Small Cell Lung Cancer Cells by Up-Regulating Survivin Through the Down-Regulation of miR-320</p>. Cancer Management and Research. Volume 12. 1129–1134. 13 indexed citations
10.
Wan, Jun, et al.. (2019). Independent prognostic value of HIF‑1α expression in radiofrequency ablation of lung cancer. Oncology Letters. 19(1). 849–857. 8 indexed citations
11.
Wan, Jun, et al.. (2018). miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway. Oncology Reports. 40(1). 272–282. 43 indexed citations
12.
Huang, Tonghai, Guangsuo Wang, Lin Yang, et al.. (2017). Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1. DNA and Cell Biology. 36(11). 947–958. 90 indexed citations
13.
Huang, Tonghai, Guangsuo Wang, Lin Yang, et al.. (2017). MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1. Cancer Biomarkers. 21(1). 221–228. 32 indexed citations
14.
Liu, Yanting, Zhaowei Chu, Qingyan Li, et al.. (2016). Downregulation of Bmi-1 suppresses epithelial-mesenchymal transition in melanoma. Oncology Reports. 37(1). 139–146. 16 indexed citations
15.
Tanwandee, Tawesak, Wattana Sukeepaisarnjaroen, Stephen L. Chan, et al.. (2016). A phase (Ph) II study of the efficacy and safety of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 34(15_suppl). 4074–4074. 8 indexed citations
16.
Zhang, Xiaoshuai, Xiaowei Yang, Zhongshang Yuan, et al.. (2013). A PLSPM-Based Test Statistic for Detecting Gene-Gene Co-Association in Genome-Wide Association Study with Case-Control Design. PLoS ONE. 8(4). e62129–e62129. 7 indexed citations
17.
Xu, Limin, Xue Zhang, Ying Wang, et al.. (2013). IP‐FCM platform detects the existence and regulator‐caused dissociation of components in naturally assembled HSP90 complex. Cytometry Part A. 85(4). 359–367. 2 indexed citations
18.
Peng, Bin, et al.. (2012). An extended association rule mining strategy for gene relationship discovery from microarray data. Journal of Statistical Computation and Simulation. 84(2). 384–396. 2 indexed citations
19.
Peng, Bin. (2011). Anti-aging effects of Ginsenoside Rg1 and it's mechanisms on brain aging rats induced by D-galactose. Chongqing Yike Daxue xuebao. 2 indexed citations
20.
Liu, Lifeng, et al.. (2005). Cloning and Construction of Plant Expression of the Coat Protein Gene of a Melon Isolate of Cucumber Mosaic Virus. Virologica Sinica. 20(3). 307–310. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026